Abstract
INTRODUCTION
The effects of transfusion of red blood cells (RBCs) on short-term and long-term morbidity and mortality in patients undergoing cardiac surgery are poorly understood. As cardiac surgery has one of the highest rates of blood transfusion among the surgeries performed, understanding the risk behind transfusion-related mortality is vital for surgical practice. Different studies have suggested that transfusion of as little as 1 unit of RBC increased mortality [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . The effect of transfusion on mortality was greater in cardiac surgery patients than other patient groups [11] . However, other investigators found contradicting results when adjusting for known risk factors [12] [13] [14] [15] [16] . The difference in findings may be attributed to confounders.
Patients receiving RBC transfusion differed significantly clinically from those who did not receive transfusion, and had a higher risk for perioperative complications and a more complex operative course [17, 18] . Because of the presence of confounders, the effect of transfusion on long-term mortality was difficult to evaluate as it may be lost among other associated risk factors. Transfused patients often had preoperative risk factors for mortality and morbidity that were also associated with the need for RBC transfusion, such as older age, female gender, smaller body surface area or anaemia [19] [20] [21] [22] [23] .
Associations between these risk factors and negative outcomes, for example, increased frequencies of acute kidney injury among anaemic patients also receiving RBC transfusion, could explain partly the increased long-term mortality rate among transfused patients [24] . Thus, differences in patient characteristics and comorbidities and not RBC transfusion itself may be an underlying reason for the higher mortality rate among transfused patients.
We hypothesized that there is no long-term effect of RBC transfusion on mortality in adult patients undergoing coronary artery bypass grafting (CABG) and that the increased mortality risk is due to other underlying risk factors. The aim of this study was to investigate whether there was a difference in long-term all-cause mortality associated with RBC transfusion in patients who underwent coronary artery surgery. We, therefore, compared long-term mortality adjusted for known risk factors in patients who did and who did not receive RBC transfusion in a prospective study on primary isolated CABG. 
MATERIALS AND METHODS

Trondheim heart surgery database
Patients and procedures
Data from consecutive adults undergoing isolated CABG surgery from 2000 through 2014 were included. Only the first entry into the database was used for survival analysis. Exclusion criteria were short-term mortality (postoperative death within 30 days), intraoperative blood loss > _700 ml, postoperative blood loss > _800 ml until the first postoperative morning or the need for reoperation following surgery (Fig. 1 ). Blood loss above the stated thresholds was considered to indicate a complicated intra-or early postoperative course with higher risk for RBC transfusion. Non-Norwegian citizens were excluded because of missing data regarding death, leaving 4014 eligible patients for the study.
All patients underwent an on-pump procedure. The cardiopulmonary bypass (CPB) circuit was primed with 1100-1500 ml of Ringer's acetate with 7500-10 000 U of heparin (Leo, Copenhagen, Denmark). Before CPB, patients were administered 300 U/kg of heparin to achieve a kaolin-activated coagulation time of > _480 s. Additional heparin was administrated when needed. All patients were given tranexamic acid (Leo) 30 mg/kg routinely before the start of CPB. After CPB, blood remaining in the circuit was retransfused to the patient, and protamine sulphate (Leo) was given to achieve an activated coagulation time within 10% of baseline. Acetylsalicylic acid was discontinued 1-3 days before surgery. Data on clopidogrel and ticagrelor were not available in the database for the entire study period and were therefore not used.
In general, a transfusion threshold of 7.0 g/dl during CPB and 8.5 g/dl postoperatively was practised. Platelets or fresh frozen plasma were considered when postoperative bleeding was above 200 ml/h. The final decision to transfuse was left to the attending physician. Transfusions were recorded during the entire hospital stay. Blood loss during surgery was estimated in categories, i.e. < _500 ml, 600 ml, 700 ml or >700 ml.
End point
The study end point was all-cause mortality with observation time starting 30 days postoperatively, denoted as long-term mortality. We compared long-term mortality between patients who received RBC transfusions during the hospital stay with patients who did not receive any RBC transfusion. Data regarding deaths were obtained from the Norwegian Cause of Death Registry , which registers deaths of all Norwegian citizens.
Statistical analysis
Statistical analyses were performed using Stata (Stata v0.13, College Station, TX, USA). Median and 95% confidence interval (CI) are provided for continuous variables because many were non-normally distributed (mean and standard deviation are provided in the Supplementary Material Table S1 ). For comparison between the transfused and the non-transfused groups, the v 2 test and the Mann-Whitney U-test were used for discrete and continuous variables, respectively. P-values < 0.05 were considered significant. Mortality was analysed with multivariate Cox proportional hazard modelling. The proportional hazard test, log-log plots and Cox-Snell residuals were used to assess model fit.
A 3-step analysis plan was employed to investigate the effects of RBC transfusion on long-term mortality, permitting separate evaluation of different types of the potential confounders. The first step was a univariate Cox regression analysis with transfusion of at least 1 unit of RBC (yes/no) as the only covariate. In the second step, the multivariate Cox regression model also included preoperative and intraoperative adjustment variables. The chosen covariates were variables that could influence RBC transfusion based on clinical knowledge and the literature [25, 26] : age, sex, preoperative haemoglobin, amount bled during the first 16 h, body mass index, hypertension, CPB time, diabetes, smoking (present or previous smoker versus never smoker) and preoperative creatinine. In the third step, the Cox regression analysis included the mentioned covariates, as well as selected postoperative complications: novel renal failure (absolute serum creatinine increase > 26 mmol/l or relative increase > 50%), prolonged mechanical ventilation (primary intubation more than 24 h or need for reintubation), acute myocardial infarction or cardiac dysfunction (use of 2 or more inotropics or intra-aortic balloon pump).
Sensitivity analysis
Additional sensitivity analyses were performed to evaluate the robustness of the results. To test whether the findings were biased from the exclusion of the patients with early mortality or observation time <30 days, a Step 3 sensitivity analysis was performed, which also included these patients. Furthermore, because there were several preoperative differences (Table 1) between the patients who did and did not receive RBC transfusion, we performed a sensitivity analysis using greedy 1:1 propensity score matching to control for residual confounding in the Cox regression analysis.
Sequential logistic regression analysis for RBC transfusion including 18 pre-and operative variables produced a propensity score for each patient (Supplementary Material Table S2 ). One patient had missing New York Heart Association Functional Classification and was excluded. The caliper width was one-fourth of the standard deviation of the propensity score, i.e. 0.0711. Another propensity score included the same variables and the postoperative complications from the Step 3 main analysis, with a caliper width of 0.0713.
The balance between the groups for covariates was assessed with absolute standardized difference in covariate means or the difference in prevalence for binomial variables. For categorical variables with more than 2 values, we compared the absolute standardized difference for all dummy pairs of the covariate. Ideally, the difference should be < _10%.
We assessed the effects of residual confounding using a univariate random effects Cox regression model for RBC transfusion between the matched groups, with all-cause mortality after 30 days following surgery as outcome.
RESULTS
Of the 4014 included patients, 1127 (28.1%) received transfusion of > _1 units of RBC and, on average, 2 units of RBC. A total of 727 Figure 1 : Flow chart of exclusion criteria and the number of patients included in the study. 1 Other surgery than isolated coronary bypass grafting, reoperation for bleeding and non-primary surgery.
(18.1%) patients died during the follow-up period, of which 298 (26.4%) patients were in the RBC-transfused group compared with 429 (14.9%) patients in the non-transfused group (P < 0.01). The observation time ranged from 30 days to 15 years (median 7.2 years, 95% CI 7.0-7.5 years). There were significant differences between the groups for several variables (Table 1 ).
In the Step 1 univariate Cox regression model, increased longterm mortality was significantly associated with RBC transfusion (Fig. 2, Table 2 ). In the Step 2 model adjusting for pre-and intraoperative variables, RBC transfusion still carried a significant mortality risk but with a lower hazard ratio (Table 2 ). In the Step 3 model also adjusting for postoperative complications, the effect of RBC transfusion on mortality was no longer significant (Table 2) . Correspondingly, survival estimates and cumulative hazards for the Step 3 model showed overlapping 95% CI for the groups with and without RBC transfusion (Fig. 3) . In the Step 3 model, age, haemoglobin concentration, creatinine concentration, smoking and diabetes were significantly associated with mortality.
In the Step 3 sensitivity analysis including all patients, also those with short-term mortality, there was no significant association of RBC transfusion with mortality (hazard ratio for RBC transfusion 1.16, 95% CI 0.96-1.41; P = 0.13, n = 4052).
In the second sensitivity analysis using propensity score matching for patients who did and did not receive RBC transfusion, it was possible to match 596 transfused patients (52.9%) when adjusting for pre-and intraoperative variables (Model 4). The transfused patients without a match had high propensity scores, indicating a high probability of requiring RBC transfusion. The median propensity score for the group that did not receive RBC transfusion was 0.081 (95% CI 0.077-0.084), as compared with 0.715 (95% CI 0.679-0.737) in the group that received RBC transfusion (Supplementary Material Figure S3 ). When we Figure S3 ). The propensity-matched groups were balanced for all variables as indicated by standardized differences < _10%, except for previous percutaneous coronary intervention in Model 4 (13%, Supplementary Material Table S2 ). We considered this acceptable.
The sensitivity analysis using propensity score matching showed no significant effect of RBC transfusion on long-term mortality for both propensity score models ( Table 2 ). The Cox-Snell residuals indicated a good fit for all models.
DISCUSSION
The main finding of the study was that the association of RBC transfusion with long-term all-cause mortality (30 days to 15 years after surgery) in adults undergoing isolated primary CABG surgery was mainly due to patient characteristics and perioperative factors. The effect of RBC transfusion was diminished and no longer statistically significant when adjusted for postoperative complications as well as pre-and intraoperative variables. Thus, most of the observed difference in mortality may be attributed to well-known factors such as age, haemoglobin concentration, smoking, diabetes and renal dysfunction. A strength of this study is that the stepwise design demonstrated that the negative effect of RBC transfusion could be due to confounding from early postoperative complications. These complications could arise because of operative factors or clinically different characteristics among the patients (Table 1) who were not adjusted for in the analysis. This study therefore suggests that the underlying comorbidities and risk factors among RBC transfused patients are an important cause of the higher rate of observed long-term mortality in transfused patients. Another strength of this study is the inclusion of sensitivity analyses that support the main findings. With propensity score matching, which is a method to remove the influence from many confounders, the effect of RBC transfusion was far from significant (P = 0.19) also in the model adjusting for pre-and intraoperative variables only. This raises the question whether the association between RBC transfusion and mortality in the main Step 2 analysis, i.e. not correcting for postoperative complications, may be due to residual confounding.
Comparison with previous studies
The present findings are in accordance with several studies showing no significant effect of RBC transfusion on long-term mortality [13] [14] [15] [16] . However, other studies have reached more ambiguous conclusions [1, 2, 4, [6] [7] [8] [9] [10] . Our study demonstrates the importance of cautious interpretation and consideration of how potential confounders were adjusted for. Dejam et al. [11] found that RBC transfusion was statistically significant in some groups, depending on patient characteristics and comorbidities, but not significant in the overall cohort. This agrees with the publication of Warwick et al. [13] who concluded that the increased long-term mortality may be due to underlying indications for RBC transfusion. Dardashti et al. showed that RBC transfusion was no longer significantly associated with long-term mortality when adjusting for preoperative haemoglobin and renal function.
In comparison, Jakobsen et al. [4] found an association between RBC transfusion and long-term mortality. However, their analysis was not adjusted for haemoglobin concentrations. Studies have shown lower survival among anaemic patients undergoing cardiac surgery [21, 26] and higher postoperative morbidity among patients with lower haematocrit without RBC transfusion [27] . Engoren et al. [2] found that RBC transfusion had a higher hazard for long-term mortality among anaemic patients but not among non-anaemic patients. Preoperative haemoglobin concentrations and RBC transfusion are highly correlated [13] . Consequently, the association of RBC transfusion and long-term mortality seen in observational studies may be due to residual confounding. As expected, patient characteristics in this study differed between the transfused and the non-transfused groups (Table 1 ). On the basis of similar observations, Jakobsen et al. discussed whether confounding may lead to overestimation of the effect of RBC transfusion in observational studies. This view was supported by the Step 3 model in this study. Murphy et al. [28] found more deaths within 3 months after cardiac surgery in patients randomized to a restrictive transfusion threshold. Their data suggest that in patients with moderate postoperative anaemia, the risks associated with not being transfused are higher than the risks associated with RBC transfusion. Their findings support our view that increased mortality in transfused patients found in some observational studies may rather be due to confounding than a true negative effect of transfusion.
In a recent study, Schwann et al. [1] stratified patients into groups with and without postoperative complications. They showed that RBC transfusion was associated with an increase in long-term mortality for the whole study population, as well as for both stratified groups. The effect was smallest in patients with the longest observation time. Surgenor et al. [6] found that RBCtransfused patients were at higher mortality risk up to 6 months postoperatively but not thereafter. van Straten et al. [5] suggested that the association of RBC transfusion with short-term mortality and long-term mortality may be different. On the basis of these findings, we excluded patients with short-term mortality from our main analysis. The sensitivity analysis supports that this exclusion did not bias our results.
We did not investigate whether the number of units transfused had an influence on mortality. Therefore, the results reflect the independent effect of RBC transfusion on long-term mortality. This strategy was supported by a previous study showing that the number of RBC units transfused was not associated with longterm mortality when adjusting for a wide range of covariates [16] .
The results from this study support our hypothesis that RBC transfusion in isolated CABG surgery has no statistically significant effect on long-term mortality. However, we cannot exclude that this may be a false-negative conclusion due to the moderate size of the study. Even so, the findings suggest that confounders for long-term mortality seen in the RBC transfused patients, such as differences in comorbidities, operative course and postoperative complications, may be the major cause for differences in the observed mortality. The effect of RBC transfusion on long-term mortality may therefore be less than previously suggested.
Limitations
The database was limited to patients undergoing cardiac surgery at 1 centre, St. Olavs University Hospital. The database is considered representative of the general population in Middle Norway. Women were under-represented because they less often undergo cardiac surgery. Therefore, separate gender effects could not be evaluated.
The transfusion policy did not change significantly during the study period, although there have been some minor changes. The postoperative transfusion threshold of haemoglobin has ranged from 8-9 g/dl, but the intraoperative transfusion policy remained essentially the same during the study period. However, this probably had little impact on the results because we did not evaluate the transfusion threshold on the outcome, the dose effect of RBC transfusion or the intra-or postoperative timing of transfusion. We cannot exclude that the results could have been different using other transfusion thresholds. The storage time of RBC units was not taken into consideration, but a systematic review has not found a definite effect of storage time on mortality or morbidity [29] .
This study demonstrates associations, not causation, and our models are not appropriate for mortality prediction in individual patients. There is a possibility that inclusion of postoperative complications may have introduced a bias to the Step 3 analysis, in that they could be triggered or influenced by transfusion.
The patients without a match in the sensitivity analysis had higher propensity scores, i.e. a higher risk for RBC transfusion and higher mortality by the end of the observation time. We cannot exclude that this may have biased the propensity scorematched analysis.
